Gustavo Guilherme Queiroz Arimatea

ORCID: 0000-0001-9141-3035
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pharmacological Effects and Toxicity Studies
  • Organ Donation and Transplantation
  • COVID-19 Clinical Research Studies
  • HIV/AIDS drug development and treatment
  • Public Health in Brazil
  • SARS-CoV-2 and COVID-19 Research
  • Renal Transplantation Outcomes and Treatments
  • COVID-19 and healthcare impacts
  • Ethics in medical practice
  • Cytomegalovirus and herpesvirus research
  • Pregnancy and Medication Impact
  • Biochemical and Molecular Research

Hospital Universitário de Brasília
2021-2023

Universidade de Brasília
2019-2021

San Antonio College
2021

Universidad Unidad
2021

This analysis, using data from the Brazilian kidney transplant (KT) COVID-19 study, seeks to develop a prediction score assist in risk stratification KT recipients. In this 1379 patients (35 sites) were enrolled, and machine learning approach was used fit models derivation cohort. A reduced Elastic Net model selected, accuracy predict 28-day fatality after diagnosis, assessed by area under ROC curve (AUC-ROC), confirmed validation The better calibration values build applicable ImAgeS score....

10.1111/ajt.16807 article EN cc-by-nc-nd American Journal of Transplantation 2021-08-20

During the pandemic, many health services were interrupted, some of them to fully guarantee attention diagnosed patients with coronavirus (Covid-19), and others protect who at risk, such as immunosuppressed patients.Objective: Present a service organization from Telemedicine professionals' perception about medical care renal transplant recipients.Methods: This is reflection carried out through review literature experience in kidney clinic university hospital Brazil.Results: For...

10.29327/213319.21.4-8 article EN Temas em Saúde 2021-01-01

Immunosuppressants (ISS) are the most crucial tools used in therapeutic regimens of transplant recipients. Nevertheless, these drugs not only ones adopted by patients; therefore, knowing possible drug-drug interactions (DDIs) between immunosuppressants and other commonly kidney recipients is essential to ensure effectiveness safety treatments. In this way, objective analyzing DDIs medications on adult with active medical records undergoing post-transplant follow-up for 4.4 years (mean).

10.22491/2357-9730.128108 article EN cc-by Clinical & Biomedical Research 2023-01-01

A bioética tange a saúde pública na medida em que relação médico-paciente, ou seja, dos prestadores de serviços e os consumidores deste serviço, tornou-se mais complexa. Além das questões autonomia respeito ao indivíduo, entraram cena, juntamente com o Estado, novas formas organização, como as comunidades organizações não governamentais. Surgiram novos conflitos morais acerca custos prevenção, diagnóstico, terapias e, consequentemente, políticas públicas se tornaram atividades sociais cada...

10.26512/rbb.v14iedsup.24132 article PT cc-by-nc-sa Revista Brasileira de Bioética 2019-04-12
Coming Soon ...